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Anticipatory Nausea (AN) is a severe side effect of chemotherapy that can lead cancer
patients to discontinue their treatment. This kind of nausea is usually elicited by the
re-exposure of the patients to the clinical context they need to attend to be treated.
There has been considerable agreement that AN represents a paradigmatic example
of Pavlovian conditioning, and within this framework, several behavioral interventions
have been proposed in order to prevent this phenomenon. However, some studies have
questioned the validity of the Pavlovian approach, suggesting that CS-US associations are
neither necessary nor sufficient for AN to occur. The data and the alternative theories
behind such criticisms are discussed. Additionally, it is suggested that animal models of
AN could be enriched by taking into account rats’ individual differences.
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INTRODUCTION
Chemotherapy treatment leads to a wide range of harmful col-
lateral effects which include hair loss, diarrhoea, fatigue, loss of
appetite, sexual dysfunction, and cognitive deficits (e.g., Kayl and
Meyers, 2006). But in addition to these distressing side effects
(perhaps to be expected given that, in essence, this treatment
works through poisoning), the major unpleasant symptom that
patients have to cope with while undergoing chemotherapy treat-
ment is nausea (e.g., Haiderali et al., 2011). When severe, this
consequence of chemotherapy dramatically reduces the patient’s
quality of life, and may even lead to discontinuation of the treat-
ment (Roscoe et al., 2011). Adequate management of nausea for
these patients has not been completely achieved through phar-
macological interventions (Hsu, 2010), so that behavioral and
cognitive therapies are being increasingly recommended (Schiff
and Ben-Arye, 2011).
In an ordinary chemotherapy schedule (e.g., Jacobsen et al.,
1993) high and low doses of cytotoxic drugs (such as cis-
platin, carboplatin, cyclophosphamide) are administered in cycles
spaced for a period of weeks. During each of those cycles,
patients may need to attend the hospital for up to six con-
secutive weeks to receive an infusion on each visit. The visit
to the hospital for the administration of the infusion can last
for hours, and the first signs of intoxication (nausea, vomit-
ing, sweating, changes in heart rate etc.) can be experienced
when patients are still in the hospital room. Later, when they
return home, sporadic nausea episodes can appear during the
next 24 h, and also during a following period of ∼5 days. These
two phases are usually referred to as acute and delayed nau-
sea, respectively (e.g., Haiderali et al., 2011). If patients under-
going chemotherapy repeatedly experience episodes of nausea,
then this can lead to a further problem known as anticipatory
nausea (AN).
PAVLOVIAN CONDITIONING OF NAUSEA IN CANCER
PATIENTS
In a given moment during the course of the treatment, can-
cer patients can experience nausea and/or vomiting before the
start of a new infusion. Originally considered as a kind of neu-
rosis, AN was finally identified in 1980 by Nesse et al. (1980)
as a case of Pavlovian conditioning, an interpretation that pre-
vails to the present day, albeit not exclusively. First, its etiology
is taken to be psychological because this kind of nausea is not
directly related to the infusion of the cytotoxic drugs; and sec-
ondly, it tends to occur when patients expect it on the basis
of some specific environmental cues or thoughts. According to
the classical conditioning model, the chemotherapy schedule can
be conceptualized as a set of learning trials. Thus, in a particu-
lar context, the administration of the cytotoxic drugs would act
as an unconditioned stimulus (US) with nauseating effects (the
unconditioned response, UR). By virtue of association with the
contextual stimuli present during the infusion sessions (condi-
tioned stimulus, CS), these effects are subsequently elicited as a
conditioned response (CR). The similarity between the UR and
the CR; the fact that AN is more easy to observe as the chemother-
apy treatment progresses (i.e., as the number of conditioning
trials increases); that the stimuli acting as the CS are usually those
related to the hospital setting (either directly perceived or imag-
ined); and that AN persists during the follow-up visits to the
hospital once the chemotherapy was completed, are four charac-
teristics that clearly fit this interpretation (e.g., Tomoyasu et al.,
1996).
The adequacy of a Pavlovian theoretical framework to account
for AN has been widely accepted, and has had not only important
implications for cancer patients but also for learning theorists.
Patients have obtained two main benefits from the condition-
ing approach to AN. First, the simple fact of knowing the
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reasons why they react as they do has been supportive and a
source of relief for them (Nesse et al., 1980). And second, two
well-established learning phenomena that reduce the efficacy of
CS-US pairings in producing an association—latent inhibition
and overshadowing—have been offered (Stockhorst et al., 1998;
Klosterhalfen et al., 2005) as possible behavioral interventions
that could help to prevent AN1. Furthermore, this line of inves-
tigation has also been very fruitful for learning psychologists.
Attempts to reproduce with laboratory animals the conditions
under which AN develops in humans has helped to provide a use-
ful paradigm for studying the laws of contextual aversion learning
(see Symonds and Hall, 2012, for a review on this topic).
However, it is also necessary to recognize that there are two
major problems that the Pavlovian framework needs to address.
First, AN affects approximately only one in four patients (Roscoe
et al., 2011), which means that factors other than CS-US con-
tingencies may be affecting the development of AN, or in other
words, that the predictive capacity of the Pavlovianmodel to iden-
tify those patients who are at risk of suffering from AN needs
to be improved (Watson et al., 1998). Second, and more intrigu-
ingly, it has been asserted (Aapro et al., 2005) that nausea can be
anticipated in patients without their having the previous experi-
ence that classical conditioning involves. In the following section
we will first consider some data that do not fit with the condi-
tioning model and the alternative theories that could account for
them.
ARE ALTERNATIVE EXPLANATIONS FOR AN NECESSARY?
A good example of why some authors have questioned the valid-
ity of the associative theory as an account of AN was provided by
Tyc et al. (1997). These authors observed that of the 45 children
(59%) who developed AN in their sample, 11 (25%) had not pre-
viously suffered from post-treatment nausea (see also Matteson
et al., 2002). This fact does not fit with learning rules in that the
supposed CR could not be elicited if the subject has not previously
experienced the UR. It might be possible to argue that experienc-
ing the UR is not necessary for conditioning, i.e., that the simple
fact of pairing the CS and the US could be enough for the for-
mation of an association. However, such an argument could be
considered as implausible and for the purposes of practical inter-
vention in the clinic it seems reasonable to consider other possible
explanations.
1Latent inhibition is a very robust effect that has been observed under a
great variety of preparations—presentations of a stimulus followed by no
consequences will subsequently retard the acquisition of its association with
any given US. Klosterhalfen et al. (2005) showed for example that AN
induced by a rotation chair was lower in subjects preexposed to that appa-
ratus. Thus, within the context of chemotherapy treatment, these authors
suggested that preexposures to the clinical cues could be useful to prevent
chemotherapy-induced AN. Overshadowing is also a well-established phe-
nomenon in associative learning—a salient cue is presented in combination
with a target CS, with the result that the capacity of that CS to predict the US
is reduced. Stockhorst et al. (1998) gave a group of cancer patients different
novel combinations of flavors during their first two infusions. At their third
clinical visit none of the 8 experimental subjects showed AN, but it was found
in two patients of the control group that had drunk water instead of the novel
tastes. It is supposed that the readiness of the flavors to become associated with
the gastric discomfort overshadowed the conditioning of the clinical cues.
Tyc et al. (1997) proposed two possible accounts for their data.
Firstly, nausea could have been directly elicited by an acute attack
of anxiety, a phenomenon known as “psychogenic” or “nervous”
nausea (Yugin, 1989). Secondly, it is known that a person can get
sick through observational learning, i.e., by viewing other people
vomiting. Given that subjects in the sample by Tyc et al., shared
the chemotherapy room, this possibility seems more than plausi-
ble (see also Cohen et al., 1986). Finally, a third possibility, which
has been increasingly analyzed during the last decade, is that the
expectancies of the patients play an important role in the develop-
ment of AN. Response expectancy theory supposes that patients
might anticipate nauseating symptoms on the basis of their pre-
vious thoughts or beliefs and that this can be a direct cause of
the occurrence of these symptoms (e.g., Montgomery et al., 1998;
Sohl et al., 2009). In this case, AN would be governed by the
same general mechanisms that operate in producing the placebo
effect, and could be observed without the necessary mediation of
a previous Pavlovian association (see Stewart-Williams and Podd,
2004, for a discussion about the relationship between the placebo
effect and Pavlovian conditioning).
It is suggested then, that patients who expect to experience
nausea, and even those who are uncertain about it, are more
likely to develop AN than patients who clearly do not expect
to get sick during the course of chemotherapy (Hickok et al.,
2001). Given that the incidence of cancer among the popu-
lation has increased over recent decades, patients may have
acquired some knowledge from the media (through films, news,
or documentaries), as well as from their friends and relatives,
about the collateral side effects induced by the chemotherapy.
The information provided by such unofficial sources, as well
as that provided by medical staff, could influence the patient’s
expectations, thus producing a kind of “nocebo” effect (Colloca
and Miller, 2011). Unfortunately, the few experimental attempts
that have sought to confirm that the cancer patient’s expectan-
cies are a causal factor for nausea have reported inconsistent
results. In one study, Shelke et al. (2008) showed that patients
in an experimental group who trusted more than controls in
the power of a new antiemetic medication, showed almost
as much nauseating symptoms as the control. (Shelke et al.,
acknowledged, however, that their intervention may not have
been enough to counteract the patient’s previous expectancies,
a possibility supported by the fact that the response expectan-
cies assessed before the start of the experimental manipulation
correlated with both the frequency and the severity of the post-
treatment nausea). In contrast, Roscoe et al. (2010) did succeed
in reducing the attacks of nausea by emphasizing the benefits
of an acupressure technique in a previously identified “high-
expectancy” group. But, unexpectedly, this manipulation also
resulted in a significant augmentation of the occurrence of nau-
sea in a group of patients who initially had low expectancies
about it.
IDENTIFYING AN RISK FACTORS BEYOND CS-US
CONTINGENCIES
We should now turn to the apparent inability of the Pavlovian
model to explain why some patients are at much higher risk
of suffering AN than others. It has already been noted that,
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according to the contingency rules that govern the formation of
associations, one might expect that all patients undergoing equiv-
alent emetogenic chemotherapy schedules—i.e., a similar number
of infusions with analogous cytotoxic drug doses—would suffer
from similar AN symptoms. However, the validity of the contin-
gency principle as the only factor that could account for AN is
questioned by certain empirical findings. Firstly, it has been noted
that the problem can occur under distinct chemotherapy regimes
that, by employing the advised cytotoxic drugs, differ in their
emetogenic capacity (van Komen and Redd, 1985; Andrykowski
et al., 1988). In addition, in some cases no differences in the num-
ber of infusions, or in the severity of postchemotherapy nausea,
have been found between those subjects who develop AN and
those who do not (Fredrikson et al., 1993; Tyc et al., 1997). Finally,
Andrykowski et al. (1988) noted that the consistency of AN was
lower than would be expected on the basis of the Pavlovian
model: in their study just 40% of patients who initially developed
AN showed this response during the next 15 infusion sessions.
Considering all of these facts, it seems necessary to accept that
some variables other than those traditionally considered by learn-
ing theorists must be modulating the conditioning of nausea in
cancer patients. Regression analyses have identified several fac-
tors, some of which can be classified as environmental or external,
and others that refer to internal differences.
EXTERNAL VARIABLES
It seems reasonable to assume that many environmental fea-
tures might affect the capacity of the patients to cope with
nausea. Certainly, the challenge that cancer patients must meet
is severe and can push them almost to their limits. Under such
extreme circumstances, it might be the case that some details
that might otherwise be regarded as irrelevant could become
much more significant in terms of managing the unwanted side
effects. For example, several studies have pointed out that the
family characteristics of the patients may help them to deal
with the collateral emetic effects of chemotherapy. Patients who
have, for instance, non-conflicting and balanced families that
allow them to speak openly about their suffering are less likely
to experience AN (see, e.g., Youngmee and Morrow, 2007). In
addition, Cohen et al. (1986) found that the characteristics of
the treatment center strongly predicted the presence of AN, and
suggested that some fine points pertaining to the chemotherapy
room, such as being within sight of basins or the absence of
entertainment or comfortable chairs, could facilitate the mani-
festation of emetic anticipatory symptoms. Further support for
this suggestion comes from recent studies (e.g., McCarthy et al.,
2012) claiming that cozy waiting and treatment rooms are nec-
essary to reduce both anticipatory anxiety and pain in cancer
patients.
Another hospital-related difference affecting patients is the
antiemetic protocol dispensed by nurses and doctors. Clearly
this practice is likely to be important as it constitutes the first
pharmacological line of defense against the emetic syndrome
induced by the chemotherapy. It is, however, far from uniform
and the unification of intervention protocols still remains an
unreached goal (e.g., Schwartzberg, 2011). Furthermore, it has
been asserted that antiemetic treatments are often incorrectly
employed by doctors and nurses (e.g., Burmeister et al., 2012;
Fernández-Ortega et al., 2012), perhaps because medical staff fail
to appreciate fully the severity of the symptoms (Foubert and
Vaessen, 2005; Majem et al., 2011). Given the close relationship
between post-treatment nausea and AN, and that reports on this
topic often recruit their sample from different hospitals, the ade-
quacy of the antiemetic intervention can be an important factor in
generating differences in AN. In this regard it should be noted that
such variations could be argued by associative theorists to explain
why similar chemotherapy regimes do not always produce equiva-
lent anticipatory symptoms. An adequate use of this prophylactic
medication could avoid, at least in some degree, the emetic capac-
ity of chemotherapy and hence would reduce the possibilities of
nausea conditioning. Thus, in a study including patients from
different hospitals, a similar number of infusions of equivalent
cytotoxic drugs should only be taken as a comparable contingency
program if there are evidences that the antiemetic protocol is also
equivalent.
INTERNAL VARIABLES
Personality variables are known to affect conditioning in humans
but, in spite of this, they are not usually theoretically integrated
into traditional associative learning models. It seems reasonable,
particularly from a practical point of view, to know if cancer
patients who develop AN do share some characteristics. Thus,
in addition to hospital and family differences, regression mod-
els have isolated some other variables that provide a profile of
those patients who are at greatest risk of suffering from AN.
These studies indicate that variables such as being less than 50
years old, having susceptibility to motion sickness or nausea dur-
ing pregnancy, and being under a state of anxiety, hostility or
depression, can account for part of the variability of the occur-
rence of AN (e.g., Roscoe et al., 2011). This risk profile can be
extended by taking into account some personality traits associated
with AN. For instance, Challis and Stam (1992) found that AN
correlated with higher scores in scales measuring suggestibility,
and van Komen and Redd (1985) have reported similar correla-
tions with traits such as future despair, social alienation, inhibited
personality style, and anxiety. Additionally, Hursti et al. (1992)
asked relapse-free cancer patients to complete several personality
scales and to report how they experienced nausea when attend-
ing chemotherapy. Their results showed that neuroticism and
inhibiting style were two dimensions that correlated with AN.
Interestingly, this same sample of subjects was further explored
by Fredrikson et al. (1993) in an attempt to determine if AN
patients were more susceptible to conditioning. Subjects in this
sample were classified as AN or Non-AN, and treated as inde-
pendent groups. Their capacity to associate visual figures with a
mild electric shock was assessed using a heart-rate measure. They
found that patients who developed AN were more easily condi-
tioned than those in the Non-AN group. Taken together, these
latter two studies suggest a relationship between personality traits
(a high score in neuroticism or introversion) and the aversive
conditioning of both nausea and fear. This conclusion, however,
needs to be treated with caution. First, the groups were compared
as if their distribution was randomized when it was not, and sec-
ondly, the possibility exists that in a retrospective study of this
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sort, the effects were generated by the chemotherapy treatment
itself.
THE USE OF INDIVIDUAL DIFFERENCES IN ANIMAL MODELS
OF AN
The difficulties of carrying out an experimental assessment of
the role of personality traits in the development of AN might be
resolved by using an animal model. Individual differences are not
only to be found in our species—several studies have demon-
strated consistent individual differences in rats and, moreover,
that some of these can be used to predict some Pavlovian related
phenomena (e.g., Robinson and Flagel, 2009). Of course there are
features of human personality that cannot be modeled in animals
as they are exclusively revealed as verbal thoughts. However, other
animal behaviors parallel reasonably well some individual char-
acteristics that, as it has just been mentioned, are present in those
cancer patients that develop AN.
On the other hand, contextual aversions modeling AN can
easily be reproduced in the rat by simply pairing a novel environ-
ment with the effects of an emetic drug. Rodríguez et al. (2000)
showed that exposures to a novel place following an injection of
lithium chloride (a fast-acting emetic drug) produce a learned
aversion that can be assessed by simply measuring the ingestion
of a novel flavor offered in that place—after a few of those trials
a novel palatable solution is consumed unwillingly. The aversive
properties acquired by the context after such training have been
evaluated through other more accurate aversive measures such as
the taste reactivity test (e.g., Limebeer et al., 2006), supporting the
validity of the model. In the next sections the possibilities of using
some animal differences to improve the modeling of AN will be
discussed.
ANIMAL DIFFERENCES IN ANXIETY
Traits labeled anxious-neurotic in humans can be assessed in rats
by using tests such as the elevated maze or defensive burying
behavior. In particular, a reluctance to enter open arms, or a fail-
ure to cover dangerous or disgusting objects, can be considered as
a sign that a rat is anxious (Ho et al., 2002). A possible way of test-
ing the influence of personality traits on Pavlovian conditioning
of nausea, therefore, could be to assess if anxious rats show better
acquisition of a context-illness association.
To our knowledge this specific investigation has not yet been
carried out, but there are some studies that support its viabil-
ity. Borta et al. (2006), for example, observed that rats with a
low tendency to enter open arms, i.e., those supposed to be more
anxious, seemed to learn more readily an association between a
tone and a shock. In another study, Walker et al. (2008) found
that results obtained in the test of defensive burying behavior
predicted stronger aversive learning in which a new cage (a con-
textual CS) was paired with attacks by a male (bites as the US)
living in that context:44% of the variability in locomotor activity
in that cage during the test (carried out when the resident male
was not present) was explained by the previous defensive burying
related behaviors that the rats showed in response to prods that
had been placed in their home cages.
The role of anxiety differences in the success of associative
interventions intended to prevent AN could also be analyzed
using animal models. Latent inhibition and overshadowing (see
Note 1), which have already been shown to reduce AN in rats
(see Symonds andHall, 2012), demand attentional processes (e.g.,
Granger et al., 2012) that could be affected by a state of acute
anxiety (Braunstein-Bercovitz et al., 2002). If anxiety disrupts
the capacity to select those more reliable environmental stim-
uli, the retardation in aversive context conditioning derived from
these interventions could be in question for these more anxious
subjects. This can be analyzed by testing if, in a preexposed or
overshadowed context, anxious rats consume less of a novel taste
than normal rats.
OTHER ANIMAL DIFFERENCES
Regressive methodology can also readily be used to assess, in a
highly controlled way, the relationship between experimentally
induced AN and other individual characteristics, even though,
unlike anxiety, these are not facilitators of aversive conditioning
in non-human animals. For example, the application of unpre-
dictable chronic mild stress (UCMS) in rats to model human
depression has no effect on contextual aversion but, interestingly,
it does impair place preference. In particular, UCMS appears
to produce anhedonia, i.e., a reduction in the capacity of the
subjects to appreciate the appetitive effects of the rewarding
drugs. (see Willner and Mitchell, 2002 for a review of these
models.)
Anhedonia is a core symptom of human depression that can
be identified in rats by simply registering its ingestion of sucrose
(e.g., Strekalova and Steinbusch, 2010; but see Matthews et al.,
1995). Thus, a possible investigation to test if depression is related
to AN could be to analyze if subjects displaying a lower prefer-
ence for sucrose are later more likely to develop AN. Similarly,
the connection between hostility and AN could be studied in
animals by using some rat strains that differ in their latency
to attack an opponent male—the shorter the latency of attack
the higher the supposed level of aggression (e.g., de Boer et al.,
2003). Considering these examples, it seems promising to use this
methodological strategy to complete a better model of AN, by see-
ing whether any other differential characteristic present in the AN
population can also be validated in rodents.
CONCLUSION
It is widely acknowledged that animal models can be a useful
first step in testing the validity of any novel antiemetic interven-
tion. And it is now clear that developing animal models of AN
that take into account individual differences will bestow certain
advantages. First, it will clearly be more efficient to test the reli-
ability of any given prophylactic intervention in animals known
to have a particular sensitivity to the conditioning of nausea.
And success in identifying the personality variables that make
some people particularly vulnerable to AN would then allow us
to focus our antiemetic efforts on such people, providing them
with more accurate treatment that is appropriate for their specific
profile. For example, relaxation techniques may be necessary in
those patients with high scores in anxiety before the application
of associative interventions in order to guarantee its maximum
efficiency. The costs involved in pharmaceutical and psychoso-
cial interventions are substantial, providing a further reason for
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concentrating our efforts on these more vulnerable patients and
giving them more adequate therapy. Finally, such studies could
pay theoretical dividends by confirming the relevance of certain
traits or response tendencies as predictors of the development
of AN.
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